Erratum: Reduction of adverse effects from intravenous acetylcysteine treatment for paracetamol poisoning: a randomised controlled trial (The Lancet (2014) 383(9918) (697–704)(S0140673613620620)(10.1016/S0140-6736(13)62062-0));Reduction of adverse effects from intravenous acetylcysteine treatment for paracetamol poisoning: A randomised controlled trial

The Lancet

Volumn 383, Issue 9918, 2014, Pages 697-704

  Bateman, D Nicholas ^a   Dear, James W ^a,b   Thanacoody, H K Ruben ^c   Thomas, Simon H L ^c   Eddleston, Michael ^a,b   Sandilands, Euan A ^a   Coyle, Judy ^a   Cooper, Jamie G ^d   Rodriguez, Aryelly ^b   Butcher, Isabella ^e   Lewis, Steff C ^e   Vliegenthart, A D Bastiaan ^b   Veiraiah, Aravindan ^a   Webb, David J ^b   Gray, Alasdair ^a  

^a ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c NEWCASTLE UNIVERSITY   (United Kingdom)

^d ABERDEEN ROYAL INFIRMARY   (United Kingdom)

^e UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; ALANINE AMINOTRANSFERASE; CHLORPHENIRAMINE; CYCLIZINE; ONDANSETRON; PARACETAMOL; PLACEBO;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANAPHYLAXIS; ARTICLE; CONTROLLED STUDY; DOSAGE SCHEDULE COMPARISON; DOUBLE BLIND PROCEDURE; DRUG DOSE REGIMEN; DRUG INTOXICATION; DRUG OVERDOSE; FEMALE; HUMAN; INCIDENCE; INFUSION RATE; INTENTION TO TREAT ANALYSIS; INTERNET; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; RETCHING; UNITED KINGDOM; VOMITING;

EID: 84894030764     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(13)62371-5     Document Type: Erratum

References (30)

1. Ferner RE, Dear JW, Bateman DN. Management of paracetamol poisoning. BMJ 2011; 342: d2218.
2. Heard KJ. Acetylcysteine for acetaminophen poisoning. N Engl J Med 2008; 359: 285-92.
3. Health and Social Care Information Centre. Hospital episode statistics, admitted patient care - England 2011-12: primary diagnosis, 4 characters table [.xls]. Nov 1, 2012. http://wwwhscic.gov.uk/catalogue/PUB08288 (accessed May 13, 2013).
4. Bronstein AC, Spyker DA, Cantilena LR, Rumack BH, Dart RC. 2011 annual report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 29th annual report. Clin Toxicol 2012; 50: 911-1164.
5. Prescott LF, Illingworth RN, Critchley JA, Stewart MJ, Adam RD, Proudfoot AT. Intravenous N-acetylcystine: the treatment of choice for paracetamol poisoning. BMJ 1979; 2: 1097-100.
6. Prescott LF, Ballantyne A, Park J, Adriaenssens P, Proudfoot AT Treatment of paracetamol (acetaminophen) poisoning with N-acetylcysteine. Lancet 1977; 310: 432-34.
7. Smilkstein MJ, Knapp JL, Kulig KW, Rumack BH. Efficacy of oral N-acetylcysteine in the treatment of acetaminophen overdose: analysis of the national multicenter study (1976 to 1985). N Engl J Med 1988; 319: 1557-62.
8. Commission on Human Medicines Paracetamol Expert Group. Benefit risk profile of acetylcysteine in the management of paracetamol overdose. April 25, 2013. http://www.mhra.gov.uk/home/groups/pl-p/documents/drugsafetymessage/ con184709.pdf (accessed May 13, 2013).
9. Rumack BH, Bateman DN. Acetaminophen and acetylcysteine dose and duration: past, present and future. Clin Toxicol 2012; 50: 91-98.
10. Lynch RM, Robertson R. Anaphylactoid reactions to intravenous N-acetylcysteine: a prospective case controlled study Accid Emerg Nurs 2004; 12: 10-15.
11. Pakravan N, Waring WS, Bateman DN. Risk factors and mechanisms of anaphylactoid reactions to acetylcysteine in acetaminophen overdose. Clin Toxicol 2008; 46: 697-702.
12. Sandilands EA, Bateman DN. Adverse reactions associated with acetylcysteine. Clin Toxicol 2009; 47: 81-88.
13. Ferner RE, Langford NJ, Anton C, Hutchings A, Bateman DN, Routledge PA. Random and systematic medication errors in routine clinical practice: a multicentre study of infusions using acetylcysteine as an example. Br J Clin Pharmacol 2001; 52: 573-77.
14. Hayes BD, Klein-Schwartz W, Doyon S. Frequency of medication errors with 21-hour acetylcysteine for acetaminophen overdose. Ann Pharmacother 2008; 42: 766-70.
15. Fathalla S, Hill S, Hodson K, Salih IS, Thomas SHL. Inaccuracies in acetylcysteine dose calculation or infusion rates in patients with and without anaphylactoid reactions. Clin Toxicol 2008; 46: 401-02.
16. British Medical Association and the Royal Pharmaceutical Society. British National Formulary, 58th edn. London: BMJ Group and RPS publishing, 2009.
17. Kerr F, Dawson A, Whyte IM, et al. The Australasian Clinical Toxicology Investigators Collaboration randomized trial of different loading infusion rates of N-acetylcysteine. Ann Emerg Med 2005; 45: 402-08.
18. Prescott LF, Donovan JW, Jarvie DR, Proudfoot AT. The disposition and kinetics of intravenous N-acetylcysteine in patients with paracetamol overdosage. Eur J Clin Pharmacol 1989; 37: 501-06.
19. Thanacoody HKR, Gray A, Dear JA, et al. Scottish and Newcastle Antiemetic Pre-treatment for paracetamol poisoning study (SNAP). BMC Clin Pharmacol 2013; 14: 20.
20. British Medical Association and the Royal Pharmaceutical Society. British National Formulary, 64th edn. London: BMJ Group and RPS publishing, 2012.
21. Simons FER, Ardusso LRF, Bilò MB, et al, for the World Allergy Organization. World Allergy Organization guidelines for the assessment and management of anaphylaxis. World Allergy Organ J 2011; 4: 13-36.
22. Whyte IM, Buckley NA, Reith DM, Goodhew I, Seldon M, Dawson AH. Acetaminophen causes an increased international normalized ratio by reducing functional factor VII. Ther Drug Monit 2000; 22: 742-48.
23. Antoine DJ, Dear J W, Starkey Lewis PJ, et al. Mechanistic biomarkers provide early and sensitive detection of acetaminophen-induced acute liver injury at first presentation to hospital. Hepatology 2013; 58: 777-87.
24. Starkey Lewis PJ, Dear J, Platt V, et al. Circulating microRNAs as potential markers of human drug-induced liver injury. Hepatology 2011; 54: 1767-76.
25. Al-Hourani K, Mansi R, Pettie J, Dow M, Bateman DN, Dear JW. The predictive value of hospital admission serum alanine transaminase activity in patients treated for paracetamol overdose. QJM 2013; 106: 541-46.
26. Brok J, Buckley NA, Gluud C. Interventions for paracetamol (acetaminophen) overdose. Cochrane Database Syst Rev 2006; 2: CD003328.
27. Wright RO, Anderson AC, Lesko SL, Woolf AD, Linakis JG, Lewander WJ. Effect of metoclopramide dose on preventing emesis after oral administration of N-acetylcysteine for acetaminophen overdose. J Toxicol Clin Toxicol 1999; 37: 35-42.
28. Carlisle J, Stevenson CA. Drugs for preventing postoperative nausea and vomiting. Cochrane Database Syst Rev 2006;3: CD004125
29. Waring WS, Pettie JM, Dow MA, Bateman DN. Paracetamol appears to protect against N-acetylcysteine-induced anaphylactoid reactions. Clin Toxicol 2006; 44: 441-42.
30. Schmidt LE. Identification of patients at risk of anaphylactoid reactions to N-acetylcysteine in the treatment of paracetamol overdose. Clin Toxicol 2013; 51: 467-72.